USANA Health Sciences, Inc. (NYSE:USNA) Short Interest Down 19.6% in April

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) saw a large decline in short interest during the month of April. As of April 30th, there was short interest totalling 209,200 shares, a decline of 19.6% from the April 15th total of 260,200 shares. Approximately 1.9% of the shares of the stock are short sold. Based on an average trading volume of 87,700 shares, the short-interest ratio is presently 2.4 days.

Analyst Ratings Changes

Separately, DA Davidson cut their price objective on USANA Health Sciences from $48.00 to $46.00 and set a "neutral" rating on the stock in a research report on Tuesday, May 7th.

USANA Health Sciences Price Performance

Shares of USNA traded up $0.56 during trading hours on Monday, hitting $47.27. The stock had a trading volume of 64,556 shares, compared to its average volume of 81,045. The firm has a market capitalization of $900.49 million, a PE ratio of 14.73, a PEG ratio of 1.40 and a beta of 0.94. The stock has a fifty day moving average price of $46.32 and a 200 day moving average price of $47.96. USANA Health Sciences has a 12 month low of $41.45 and a 12 month high of $69.60.

Insider Transactions at USANA Health Sciences

In other USANA Health Sciences news, Chairman Kevin Guest sold 11,011 shares of the company's stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $49.00, for a total value of $539,539.00. Following the completion of the sale, the chairman now owns 10,491 shares of the company's stock, valued at $514,059. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other USANA Health Sciences news, Chairman Kevin Guest sold 11,011 shares of the company's stock in a transaction dated Monday, March 11th. The shares were sold at an average price of $49.00, for a total transaction of $539,539.00. Following the completion of the sale, the chairman now directly owns 10,491 shares in the company, valued at $514,059. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, COO Walter Noot sold 5,240 shares of USANA Health Sciences stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $49.05, for a total value of $257,022.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 34,286 shares of company stock valued at $1,634,010. Insiders own 0.33% of the company's stock.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Pacer Advisors Inc. boosted its stake in shares of USANA Health Sciences by 75.7% in the fourth quarter. Pacer Advisors Inc. now owns 337,371 shares of the company's stock worth $18,083,000 after acquiring an additional 145,373 shares during the period. West Coast Financial LLC bought a new position in USANA Health Sciences in the 3rd quarter worth approximately $2,469,000. Vanguard Group Inc. grew its holdings in USANA Health Sciences by 2.5% during the 3rd quarter. Vanguard Group Inc. now owns 1,567,182 shares of the company's stock valued at $91,853,000 after buying an additional 38,533 shares in the last quarter. Assenagon Asset Management S.A. grew its holdings in USANA Health Sciences by 58.9% during the 1st quarter. Assenagon Asset Management S.A. now owns 82,199 shares of the company's stock valued at $3,987,000 after buying an additional 30,485 shares in the last quarter. Finally, Pzena Investment Management LLC raised its position in shares of USANA Health Sciences by 3.1% during the first quarter. Pzena Investment Management LLC now owns 785,344 shares of the company's stock valued at $38,089,000 after buying an additional 23,729 shares during the last quarter. 54.25% of the stock is owned by hedge funds and other institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.